Standards & Regulation

An industry consortium is tackling one of pharma’s biggest drug-related challenges.

It’s time for pharma companies to embrace digital technologies.

IFPMA’s Director-General, Thomas Cueni, outlines how companies worldwide can foster long-term tech transfer partnerships.

Companies must adapt to the requirements of rigorous remote inspections.

Welcome to Part II of our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

A best practice competition developed to encourage labs to pursue more efficient cold storage is now on for 2022.

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

After other defendants in the case settle, Teva is left to face the music in New York alone.

A new report has exposed a Humira US price hike that dwarfs the rises in the price of other drugs.